医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Announcement: RIHC Sets Sail for Global Business

2016年03月19日 AM12:47
このエントリーをはてなブックマークに追加


 

PHNOM PENH, Cambodia

Rorine International Holding Corporation (Company Number: 9353333) has been listed (RIHC) on OTC markets in America and RIHC subsidiaries include:-

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160318005669/en/

RIHC : Latest Update on OTC Share market (Graphic: Business Wire)

RIHC : Latest Update on OTC Share market (Graphic: Business Wire)

1World Global Corporation

1World Cambodia Holdings

RICH International Entertainment

RICH Internet Ltd. Co.

RICH International Entertainment

RICH International Investment Ltd.

Rorine (Shenzhen) Investment Ltd.

Guangzhou Lv Sheng Health Consultancy Co. Ltd.

Guangzhou Tong De Diabetes Specialist Hospital

Zhong Sheng (M) Biotechnology Cell Insurance Centre

We predict future global economic development trends, based on current trends, to create a super multinational.

At the same time, we have set up a team of experts consisting of the best brains in marketing, business management as well as international investment to manage ASEAN enterprises out of our headquarters in Cambodia. The expert team, endowed with professionalism, pragmatism, keen business acumen and a passion for excellence, is entrusted with the mission of running various financial investments, business operations and highly specialised development projects overseas. The team represents one of the most responsible and societal-driven groups in ASEAN.

We lead our subsidiaries of diversified business concerns into different investment spectra to minimize risks. Presently our footprint covers real estate, financial investment, food & beverages, entertainment & gaming, video game, plantation as well as holiday resort. Our gold mine in Cambodia is running a second probe, and is expected to start its mining operations in June. The tin mining business in Indonesia kicked off in March 2016. After the mining activities, the site will be converted into a cultural tourist resort, complete with a cultural centre, an educational centre, a rehab centre, high-class standalone bungalows and the world’s largest peacock park, the entire project of which has been fully endorsed by the local government.

Having rooted firmly in China, Rorine International began to roll out its health industry brick-and-mortar projects all over China. With its advanced patented technology in biotechnology, it set foot initially in Guangzhou and Shenzhen, with the intention of spreading to various major cities in China. Meanwhile, we set up Tong De Diabetes Specialist Hospital in Guangzhou and linked its Type II diabetes treatment to 100 top 3 hospitals in mainland China. At the same time, we registered a patent throughout South-east Asian countries and established 100 diabetes treatment centre within the region.

Rorine International and Zhong Shen (Shenzhen) Health Investment Co. Ltd jointly created the largest cell insurance centre in South-east Asia and established Zhong Shen (M) Health Investment Co. Ltd in March 2016. The company plans, in 2 years, to store healthy cells from at least 500,000 families via an innovative business model!

Today, holding on to the company philosophy of ‘aggressiveness, pragmatism, rigour and unity’, we will continue to explore innovative technology and uplift our quality to propel the company into a world class label. We reaped a good harvest last year, gracefully transitioned from steady risk into growth phase. We foresee this new year, under the able leadership of our wise Board of Directors, will bring even better performance, with the Group forming strategic alliances with various enterprises in other industries.

Riding on its inherent strength and integrated resources, Rorine International is going to prop up its listed shares, elevating it from the initial value of USD0.60 to USD1.10.

Rorine International owes its striking achievements to various trades and people from all walks of life. With a new unique financial investment model, Rorine International will help a lot more caring enterprises in China to prosper via merger and acquisition, buy-over, strategic investment etc so as to knock together on the door of NASDAQ in America. We hope to get listed on the main board by 2018, at an IPO price of USD30 per share, so that the big Rorine International family can scale the summit of riches and realize our dreams hand-in-hand.

Thank You.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160318005669/en/

CONTACT

Rorine International Holding Corporation
Hugo Cheah, +60122928816

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″
  • Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class Profile as a First-Line Targeted Therapy in Patients With ROS1-Positive Non-Small Cell Lung Cancer
  • Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan
  • 武田呈报ALUNBRIGTM (brigatinib)治疗ALK阳性非小细胞肺癌枢纽性2期ALTA试验的更新结果
  • GenePeeks Expands Distribution to India with Exclusive Agreement with CORE Diagnostics